Enzyme Engineering

& Industrial Fermentation

Enzymes are widely used as biocatalysts in the production or processing of a wide range of products including food, beverages, animal feeds, detergents, pharmaceuticals and textile products. Naturally occurring enzymes are often unstable or perform sub-optimally when moved from the biological to the industrial sphere.

Therefore, since the advent of protein engineering there have been efforts to improve these enzyme properties, and even to devise enzymes with novel specificities capable of producing types or quantities of metabolites not normally achievable in natural products. Such improvements or changes can often be challenging: enzyme activity depends on specific and highly complex structures, sometimes formed from multiple protein components, and requiring associated factors or metal ions to operate. Frequently, enhancing one desirable property comes at the cost of impairing another.

Mewburn Ellis has a long history of working with our clients in this fast-moving and competitive field. For example, we’ve been involved in protecting the ground-breaking innovations on the serine protease subtilisin (used for example in detergents and in food processing) since 1980s, and in multiple other enzymes in different fields such as brewing, biofuels and biopolymers. The Mewburn team has regularly and successfully defended patents covering our clients’ enzyme technologies at the EPO and assisted them in enforcing those patents before national courts. Engineered enzymes are typically produced in host species such as bacteria, yeasts and filamentous fungi and we also have many years’ experience in dealing with the fermentation technologies used for growing these microorganisms, and recovering the enzymes from them, whether at laboratory or industrial scale.

As more and more powerful computation tools are developed for determining and modelling protein structures, so protein engineers are increasingly able to analyse the structure-function characteristics for rationale design of novel enzymes, which can then be tested in large scale functional screening processes. Once again, our specialised team here is able to assist at our clients with obtaining protection for their intellectual property in the latest bioinformatics innovations in the enzyme space.

Open pages of Green IP Report

Green IP Report

Patents are both a driver and a barometer of innovation

Our report examines the role of patents in making innovative ‘green’ technologies into a reality as well as how the patent landscape can be used to identify opportunities for partnering, collaboration and investment.

We share our enthusiasm and admiration for commercially-focused innovation across a diverse range of technologies, from repurposing carbon dioxide to make protein-rich foods, to the multi-faceted approach to a circular plastics economy. We also discuss the tantalising prospect of AI-mediated renewable energy supply, and the harnessing of battery tech from the EV boom to drive energy efficiency in consumer devices. This report reflects our passion for technology solutions that tackle our shared global challenge.

Download the Report

Read our Blogs

UPC Weekly - About time

UPC Weekly - About time

by Matthew Naylor

UPC Weekly brings you timely, thoughtful and joined-up insight into the evolving landscape of patent litigation at the Unified Patent Court. 2026 Week 40 Time pressure is a constant factor in UPC ...

Meet the Estrobolome: The Gut Microbiome's Hidden Role in Hormone Regulation

Meet the Estrobolome: The Gut Microbiome's Hidden Role in Hormone Regulation

by Sarah Harvey

Much of the discussion around the gut microbiome focuses on digestion, inflammation or related areas such as metabolic health. However, the relationship between the gut microbiome and hormones is not ...

Beyond the Dressing: Where Advanced Wound Care Is Heading

Beyond the Dressing: Where Advanced Wound Care Is Heading

by Chloe Flower

Chronic wounds remain a significant clinical and economic challenge. But the most interesting change in wound care is not simply the development of better dressings. It is the sector’s transition ...

Iberdomide's FDA approval: a milestone for molecular glues, CELMoDs and targeted protein degradation

Iberdomide's FDA approval: a milestone for molecular glues, CELMoDs and targeted protein degradation

by Annabel Cardno

Over the last few years, targeted protein degradation (TPD) has evolved into one of the most active fields of drug discovery and biotechnology. Much of the recent attention has focused on emerging ...

UPC Weekly - The latest on preliminary injunctions at the UPC – Part 2

UPC Weekly - The latest on preliminary injunctions at the UPC – Part 2

by Aled Richards-Jones

UPC Weekly brings you timely, thoughtful and joined-up insight into the evolving landscape of patent litigation at the Unified Patent Court. 2026 Week 38 This is Part 2 of our survey of recent PI ...

UPC Weekly - The latest on preliminary injunctions at the UPC – Part 1

UPC Weekly - The latest on preliminary injunctions at the UPC – Part 1

by Aled Richards-Jones

UPC Weekly brings you timely, thoughtful and joined-up insight into the evolving landscape of patent litigation at the Unified Patent Court. 2026 Week 37 Since our last UPC Weekly instalment on ...

Learn More
ME Forward Masthead White 2